Comparison of Clinical Profile and Outcomes of Japanese Encephalitis and Acute Encephalitis Syndrome among Rural Children.


Journal

Indian journal of pediatrics
ISSN: 0973-7693
Titre abrégé: Indian J Pediatr
Pays: India
ID NLM: 0417442

Informations de publication

Date de publication:
10 2023
Historique:
received: 18 05 2022
accepted: 31 10 2022
medline: 14 9 2023
pubmed: 11 2 2023
entrez: 10 2 2023
Statut: ppublish

Résumé

The study compared the clinical profile and outcomes of Japanese encephalitis (JE) and acute encephalitis syndrome (AES) in children. Fifty-six consecutive children with symptoms fulfilling the WHO clinical case definition of AES from June 2018 to June 2020 were included in the study. All patients who tested positive for either serum or cerebrospinal fluid (CSF) anti-JE-IgM antibodies were JE patients (n = 24) and compared with non-JE AES cases (n = 32). Fever, seizures, and altered sensorium were the most common presenting symptoms. Low GCS, status epilepticus, meningeal irritation, raised CSF protein, and INR > 1.5 of JE children showed significant association with mortality (p value < 0.05), whereas only low GCS showed significant association in non-JE AES cases. The JE-specific mortality rate was 29%, which was less than the mortality rate of non-JE AES children at 41%. Both JE and non-JE AES children had a similar clinical profile, but only the JE children's poor clinical and laboratory parameters were associated with adverse outcomes.

Identifiants

pubmed: 36765003
doi: 10.1007/s12098-022-04424-5
pii: 10.1007/s12098-022-04424-5
doi:

Substances chimiques

Antibodies, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1038-1040

Subventions

Organisme : Indian Council of Medical Research
ID : ICMR/VIR/2/2018/ECD-I

Informations de copyright

© 2023. The Author(s), under exclusive licence to Dr. K C Chaudhuri Foundation.

Références

Venkatesan A, Tunkel AR, Bloch KC, et al; International Encephalitis Consortium. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis. 2013;57:1114–28.
Halstead SB, Jacobson J. Japanese encephalitis. Adv Virus Res. 2003;61:103–38.
doi: 10.1016/S0065-3527(03)61003-1 pubmed: 14714431
Ministry af Statistics and Programme Implementation, Government of India. EnviStats India 2021. Available at: https://mospi.gov.in/documents/213904//958018//1617190446306_ES1_2021_Complete.pdf//07279fbb-5ff5-ee38-23fd-a5b64645b9fe . Accessed on 20 July 2022.
Solomon T, Thao TT, Lewthwaite P, et al. A cohort study to assess the new WHO Japanese encephalitis surveillance standards. Bull World Health Organ. 2008;86:178–86.
doi: 10.2471/BLT.07.043307 pubmed: 18368204 pmcid: 2647413
Sathish N, Manayani DJ, Shankar V, Abraham M, Nithyanandam G, Sridharan G. Comparison of IgM capture ELISA with a commercial rapid immunochromatographic card test & IgM microwell ELISA for the detection of antibodies to dengue viruses. Indian J Med Res. 2002;115:31–6.
pubmed: 12138661
Lewthwaite P, Begum A, Ooi MH, et al. Disability after encephalitis: development and validation of a new outcome score. Bull World Health Organ. 2010;88:584–92.
doi: 10.2471/BLT.09.071357 pubmed: 20680123 pmcid: 2908971
Kulkarni R, Sapkal GN, Kaushal H, Mourya DT. Japanese Encephalitis: A Brief Review on Indian Perspectives. Open Virol J. 2018;12:121–30.
doi: 10.2174/1874357901812010121 pubmed: 30288200 pmcid: 6142657
Kumar R, Tripathi P, Singh S, Bannerji G. Clinical features in children hospitalized during the 2005 epidemic of Japanese Encephalitis in Uttar Pradesh. India Clin Infect Dis. 2006;43:123–31.
doi: 10.1086/505121 pubmed: 16779737
Roberts A, Kesarwani V, Gupta R, Gandhi S. Electroactive reduced graphene oxide for highly sensitive detection of secretory non–structural 1 protein: A potential diagnostic biomarker for Japanese encephalitis virus. Biosens Bioelectron. 2022;198:113837.
doi: 10.1016/j.bios.2021.113837 pubmed: 34864242
Turtle L, Solomon T. Japanese encephalitis — the prospects for new treatments. Nat Rev Neurol. 2018;14:298–313.
doi: 10.1038/nrneurol.2018.30 pubmed: 29697099

Auteurs

Anup Itihas (A)

Department of Pediatrics, Mahatma Gandhi Institute of Medical Sciences (MGIMS), Sewagram, Wardha, Maharashtra, 442102, India.

Smita Jategaonkar (S)

Department of Pediatrics, Mahatma Gandhi Institute of Medical Sciences (MGIMS), Sewagram, Wardha, Maharashtra, 442102, India.

Manish Jain (M)

Department of Pediatrics, Mahatma Gandhi Institute of Medical Sciences (MGIMS), Sewagram, Wardha, Maharashtra, 442102, India. manish@mgims.ac.in.

Rahul Narang (R)

All India Institute of Medical Sciences, Bibinagar, Telangana, India.

Varsha Chauhan (V)

Department of Pediatrics, Mahatma Gandhi Institute of Medical Sciences (MGIMS), Sewagram, Wardha, Maharashtra, 442102, India.

B V Tandale (BV)

ICMR-National Institute of Virology, Epidemiology Group, Pune, Maharashtra, India.

Shilpa Tomar (S)

ICMR-National Institute of Virology, Hepatitis Group, Pune, Maharashtra, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH